ScienceDaily

Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s

Blocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders. The discovery could help researchers repurpose existing drugs for conditions including traumatic brain injury, Alzheimer’s, Parkinson’s, depression, and schizophrenia.

By ScienceDaily

1 min read
Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Medical Science

Related Insights